Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Stabilization of Metastatic Myxopapillary Ependymoma with Sorafenib

Stabilization of Metastatic Myxopapillary Ependymoma with Sorafenib Abstract We report on a 59-year old woman with three huge intrathoracal masses that were accidentally diagnosed when she consulted a physician for upper abdominal discomfort. A biopsy revealed that they were metastases of a coccygeal myxopapillary ependymoma, resected 20 years before. As neither resection, debulking, nor radiation therapy were considered to be indicated, systemic therapy with temozolomide was started. At the first evaluation after four months, the metastases had progressed. Imatinib delayed the progression, but had to be stopped after six months because of critical increased pleural effusion. Using the multikinase inhibitor sorafenib, the disease was stabilized and an acceptable quality of life could be obtained for one year. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Rare Tumors SAGE

Stabilization of Metastatic Myxopapillary Ependymoma with Sorafenib

Rare Tumors , Volume OnlineFirst: 1 – Aug 1, 2012

Stabilization of Metastatic Myxopapillary Ependymoma with Sorafenib

Rare Tumors , Volume OnlineFirst: 1 – Aug 1, 2012

Abstract

Abstract We report on a 59-year old woman with three huge intrathoracal masses that were accidentally diagnosed when she consulted a physician for upper abdominal discomfort. A biopsy revealed that they were metastases of a coccygeal myxopapillary ependymoma, resected 20 years before. As neither resection, debulking, nor radiation therapy were considered to be indicated, systemic therapy with temozolomide was started. At the first evaluation after four months, the metastases had progressed. Imatinib delayed the progression, but had to be stopped after six months because of critical increased pleural effusion. Using the multikinase inhibitor sorafenib, the disease was stabilized and an acceptable quality of life could be obtained for one year.

Loading next page...
 
/lp/sage/stabilization-of-metastatic-myxopapillary-ependymoma-with-sorafenib-PI7iDZ0fkd

References (28)

Publisher
SAGE
Copyright
© 2012 SAGE Publications.
ISSN
2036-3613
eISSN
2036-3613
DOI
10.4081/rt.2012.e42
Publisher site
See Article on Publisher Site

Abstract

Abstract We report on a 59-year old woman with three huge intrathoracal masses that were accidentally diagnosed when she consulted a physician for upper abdominal discomfort. A biopsy revealed that they were metastases of a coccygeal myxopapillary ependymoma, resected 20 years before. As neither resection, debulking, nor radiation therapy were considered to be indicated, systemic therapy with temozolomide was started. At the first evaluation after four months, the metastases had progressed. Imatinib delayed the progression, but had to be stopped after six months because of critical increased pleural effusion. Using the multikinase inhibitor sorafenib, the disease was stabilized and an acceptable quality of life could be obtained for one year.

Journal

Rare TumorsSAGE

Published: Aug 1, 2012

Keywords: coccygeal myxopapillary ependymoma; mixed axonal demyelinating; polyneuropathy; sorafenib

There are no references for this article.